Harrow Health (HROW) Stock Statistics & Valuation Metrics

Harrow Health has a market cap or net worth of $1.50B. The enterprise value is $1.68B.

Harrow Health has 37,229,706 shares outstanding. The number of shares has decreased by -2.65% in one year.

Harrow Health’s return on equity (ROE) is -0.10 and return on invested capital (ROIC) is 11.97%.

The current PE Ratio of Harrow Health is ―. Harrow Health’s PEG ratio is 4.91.

In the last 12 months, Harrow Health had revenue of 272.30M and earned -5.14M in profits. Earnings per share was -0.14.

In the last 12 months, operating cash flow was 43.86M and capital expenditures -929.00K, giving a free cash flow of 42.94M billion.

Harrow Health pays an annual dividend of ―, resulting in a dividend yield of ―

Harrow Health upcoming earnings date is May 11, 2026, After Close (Confirmed).

Harrow Health as a current ratio of 2.20, with Debt / Equity ratio of 480.45%

In the past 12 months, Harrow Health has paid 1.21M in taxes.

Harrow Health EV to EBITDA ratio is 35.31, with an EV/FCF ratio of 46.08.

Harrow Health has $72.93M in cash and marketable securities with $251.98M in debt, giving a net cash position of -$179.05M billion.

Gross margin is 75.05%, with operating margin of 13.37%, and net profit margin of -1.89%.

The average price target for Harrow Health is $68.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy